Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
EuroEyes International Eye Clinic Limited ( (HK:1846) ) has issued an update.
EuroEyes International Eye Clinic Limited reported that it performed 7,598 eye surgeries in the first quarter of 2026, according to preliminary unaudited figures. This represents an increase of about 9% from the 6,997 procedures carried out in the same period of 2025.
The company attributed the growth primarily to stronger performance in its Switzerland operations, underscoring the importance of that market to the Group’s overall expansion. The announcement signals continued volume growth in its core surgical business, though management cautioned investors that the data are preliminary and urged care in trading the company’s shares.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited is a specialist medical services provider focused on eye surgery, operating a network of clinics with a particular presence in Europe, including Switzerland. The Group offers a range of corrective and refractive eye procedures, targeting patients seeking surgical solutions for vision improvement in its key markets.
Average Trading Volume: 107,440
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$863.4M
For detailed information about 1846 stock, go to TipRanks’ Stock Analysis page.